| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 4 | |
| #2 | Australia | 3 | |
| #3 | Canada | 3 | |
| #4 | United States | 2 | |
| #5 | WIPO (World Intellectual Property Organization) | 2 | |
| #6 | China | 1 | |
| #7 | Republic of Korea | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Microorganisms | |
| #5 | Fermentation |
| # | Name | Total Patents |
|---|---|---|
| #1 | Shiku Hiroshi | 10 |
| #2 | Nagura Kenji | 3 |
| #3 | Harada Naozumi | 3 |
| #4 | Urushihara Masahiro | 3 |
| #5 | Nagaike Kazuhiro | 1 |
| #6 | Hishida Tadashi | 1 |
| #7 | Kageyama Shin-Ichi | 1 |
| #8 | Kenji Nagura | 1 |
| #9 | Naozumi Harada | 1 |
| #10 | Masahiro Urushihara | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2014163176A1 | Method for producing ny-eso-1 protein | |
| CA2649269A1 | Protein complex and process for producing the same | |
| AU2003296083B8 | Vaccines comprising polynucleotides | |
| US2004198684A1 | Vaccine comprising a polynucleotide encoding an antigen recognized by a CD4+ helper T-cell and a polynucleotide encoding a tumor specific or associated antigen recognized by a CD8+ CTL | |
| AU2003261843A1 | Method and composition for regulating the activity of regulatory t cells | |
| AU2002304165B9 | Polynucleotide vaccine |